Olympus Corporations’ Odin Medical receives US FDA clearance for first cloud-based AI endoscopy system for colonoscopy
Posted:
Odin Medical, an Olympus Corporation company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the first cloud-based AI technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures, the CADDIE computer-aided detection (CADe) device.
The wearable combines AI and neurotechnology to modulate the nervous system to help alleviate functional limitations caused by tremors. The company's AI continuously adjusts stimulation parameters to provide therapy that calms tremors and helps restore motor control.
Read more here.
A technology-driven overhaul of the NHS could add £40bn a year to the UK economy and increase healthy life expectancy for millions, a new report suggests.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us